Results from the first randomized clinical trial in the United States to compare a sirolimus-eluting balloon (DEB) to a ...

A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis ...

CHICAGO, May 8 (Reuters) - Enthusiasm for drug-infused heart stents led doctors to test the limits of their effectiveness, resulting in their widespread use for conditions not approved by U.S.

"TCT 2025: Elixir Medical’s arterial implant drops coronary events by nearly 50%" was originally created and published by ...

A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis ...

Drug-eluting stents (DESs) have revolutionized the world of interventional cardiology. In many countries worldwide, DESs account for approximately 80% of all stents implanted. [1] When compared with ...

CHICAGO – Compared with a bare-metal stent, the use of a stent with a biodegradable polymer that releases the drug biolimus resulted in a lower rate of major adverse cardiac events at 1 year among ...

July 29 -- TUESDAY, July 28 (HealthDay News) -- Rapid dissemination of new data about the risks posed by drug-eluting stents led to an almost immediate decrease in the use of the stents, according to ...

Limiting the use of drug-eluting stents for reducing restenosis after percutaneous coronary intervention saves costs without affecting the rate of death within a year, according to a study published ...

Results from the first randomized clinical trial in the United States to compare a sirolimus-eluting balloon (DEB) to control ...

LONDON (Reuters) - European cardiologists called on Friday for greater use of stents, in a move that could boost demand for the tiny scaffolds that are used to prop open clogged arteries. The European ...

Please provide your email address to receive an email when new articles are posted on . The FDA’s Circulatory System Devices Panel advised that for a stent graft system to treat patients with ...